9:36 Thanks, Kim. And good morning, everyone. Throughout my section, I will be discussing our performance on a pro forma basis, which has been adjusted for the divestitures of Red Valve, ABEL and TerraSource Global. We believe this provides a better assessment of our ongoing operations. And you will find a reconciliation of reported and pro forma results in the appendix of the earnings slide deck. 9:59 During the fiscal first quarter, we delivered pro forma revenue of $726 million, an increase of 9%, or 10% excluding the impact of foreign currency. This growth was led by a strong performance within our Advanced Process Solutions segment and improved pricing across all three operating segments. As Kim mentioned earlier, the global supply chain and labor market challenges escalated throughout the quarter, resulting in higher transportation costs, supply chain challenges across both raw materials and components and increased labor-related costs, including overtime and outsourcing. We continue to see elevated inflation across our supply chain, resulting in price-cost coverage of approximately 65% for the quarter, which was in line with our expectations. 10:54 In response to the continued inflationary headwinds, we have taken additional pricing actions and expect our price-cost coverage to improve to approximately 100% as we move through the rest of the fiscal year. We reported GAAP net income of $49 million, or $0.67 per share, a decrease from $1.01 per share in the prior year, primarily due to a gain on the sale of Red Valve last year. 11:22 Adjusted earnings per share of $0.94 came in at the high end of our expectations, but was down $0.02 or 2% compared to the prior year as inflation, unfavorable mix and an increase in strategic investments more than offset higher volume, favorable pricing and productivity improvements, including synergies. 11:47 Pro forma adjusted EBITDA of $130 million decreased 4%, while adjusted EBITDA margin of 17.9% decreased 250 basis points, primarily due to inflation and unfavorable mix. We had cash flow from operations of $45 million in the quarter, which was better than our original expectations, primarily due to continued strong working capital performance in APS and Batesville. Compared to the prior year, cash flow was lower, primarily due to an increase in cash paid for taxes. 12:25 Capital expenditures were approximately $10 million, which was lower than expected due to continued delays from our suppliers which we anticipate will persist through the year. We continue to focus on high-return investments for our business, particularly in the areas of growth and innovation as well as automation to improve overall efficiency. 12:47 Finally, total backlog, $1.72 billion, increased 30% compared to the prior year and 3% sequentially, driven by a healthy industrial demand environment and solid orders in both APS and MTS. We are pleased with the strength of our backlog and the foundation it provides as we move forward with approximately 23% of the backlog scheduled for beyond the next 12 months. 13:18 Moving to segment performance. Pro forma APS revenue of $315 million increased 19%, or 22% excluding the impact of foreign currency, driven by higher volume of large plastics projects, favorable pricing and higher aftermarket parts and service revenue. We saw a modest impact on our ability to deliver certain aftermarket parts due to supply chain delays and shortages. In response, we've established a cross-functional task force and brought in additional temporary resources to improve capacity and work with our suppliers to optimize delivery schedules to help minimize the impact over the full year. Despite the challenges to aftermarket revenue, we were pleased to see another strong performance in aftermarket orders in the quarter with double-digit year-over-year and sequential growth. 14:14 Pro forma adjusted EBITDA of $55 million increased 18%, while adjusted EBITDA margin of 17.4% decreased 10 basis points from the prior year as operating leverage from higher volume, favorable pricing and productivity improvements were offset by inflation, unfavorable mix due to a higher proportion of large plastics projects and strategic investments. 14:39 Margin in the quarter was lower than we initially expected, primarily due to the lower mix of aftermarket revenue as well as some isolated operational inefficiencies resulting from recent restructuring actions we've taken. We have dedicated resources focused on addressing these inefficiencies and expect this to be largely mitigated in our fiscal second quarter. Order backlog of $1.3 billion increased 27% year-over-year, or 36% excluding the impact of foreign currency, primarily driven by an increase in orders for large polyolefin systems. Backlog was flat sequentially and continues to provide a strong foundation for the remainder of fiscal '22 and beyond. 15:30 The pipeline for large plastics projects remains healthy. And we continue to be encouraged by the opportunities we see across the strategic end markets of food, recycling, biopolymers and battery. While these markets are relatively small portions of our business today, we are confident that our efforts in developing innovative products and solutions and forging strategic partnerships will position us well for future growth in these areas. 16:00 Turning to Molding Technology Solutions. Revenue of $249 million increased 5% compared to the prior year, or 6% excluding the impact of foreign currency, with higher volume in both injection molding and hot runner equipment, particularly for applications related to automotive, construction and packaging. We saw a normalization in orders and revenue for medical applications, which was in line with our expectations due to the elevated COVID-related demand in the prior year. 16:36 Adjusted EBITDA of $52 million increased 7%, while adjusted EBITDA margin of 20.8% increased 40 basis points as favorable pricing and productivity improvements, including synergies, and operating leverage from higher volumes were partially offset by inflation. We continue to deploy the Hillenbrand operating model in the MTS segment, particularly within the injection molding product line where we expect to achieve sustained margin improvement over the coming years. 17:11 The labor market in North America continues to be a significant challenge and was exacerbated by the impacts of the Omicron variant over the past quarter. We continue to focus on our recruitment and retention efforts while also evaluating additional automation opportunities to improve efficiency. We had a strong quarter of order intake, particularly within the injection molding product line, resulting in order backlog of $406 million, up 39% compared to the prior year and 11% sequentially. 17:50 Turning to Batesville. As a reminder, we faced a difficult comp against the prior year where we saw volume and margin at their highest levels in nearly a decade. With that, Batesville performed above our expectations for both revenue and margin given the unfortunate COVID surge related to the Omicron variant. Revenue of $163 million decreased 1% compared to the prior year due to lower burial volume, primarily resulting from an estimated decrease in death associated with the COVID-19 pandemic and an estimated increased rate at which families opted for cremation, partially offset by improved average selling price. While we are closely monitoring the continued impacts of COVID-19, we continue to expect deaths to normalize as we progress through the second half of fiscal year '22. 18:46 Adjusted EBITDA of $41 million decreased 23%. And adjusted EBITDA margin of 24.9% declined 680 basis points compared to the prior year as inflation, higher transportation premiums and lower volume more than offset the impact of the price increase we took on October 1. In response to continued inflationary pressure in key commodities such as steel, wood and fuel, we implemented an additional price surcharge effective January 1 19:20 Since the surcharge is on a dollar-for-dollar basis, we will see a dilutive impact to margins. As we've discussed before, the Batesville team has been fully focused on meeting the elevated demand needs of their customers throughout the pandemic, and we are proud of what the team has accomplished. When demand normalizes, the business plans to reallocate resources to drive productivity projects. 19:46 Turning to the balance sheet. Net debt at the end of the first quarter was $766 million with a net debt-to-adjusted EBITDA ratio of 1.5x, which was essentially flat on a sequential basis. As of quarter end, we have liquidity of approximately $1.3 billion, including $447 million in cash on hand and the remainder available under our revolving credit facility. As of December 31, we had no borrowing on our revolver and no near-term debt maturities due. 20:23 Moving to capital deployment. We returned approximately $45 million to shareholders during the quarter through the previously announced repurchase of approximately 620,000 shares for $29 million and $16 million through quarterly dividend. Following those repurchases, we announced a new share repurchase authorization of $300 million, which replaced the remaining balance under the prior program and provides additional flexibility in how we deploy capital going forward. 20:55 As you know, we maintain a disciplined approach to capital allocation with a focus on maximizing long-term shareholder returns. Our top priority for capital continues to be strategic investments to drive profitable growth in our large product platforms in APS and MTS. Additionally, we continue to evaluate our M&A pipeline for strategic targets that we expect will accelerate our growth and provide a high return. We also continue to consider opportunistic share repurchases. 21:32 Now let me conclude my prepared remarks with an update on our full year and second quarter outlook. As a reminder, our guidance is on a pro forma basis which excludes the results of the divested Red Valve, ABEL and TerraSource Global businesses. As the basis for our outlook, we continue to expect supply chain disruptions, high transportation costs, labor market shortages and currency to remain a headwind through the end of our fiscal year. 22:01 Additionally, we expect commodity inflation to remain elevated through at least our fiscal third quarter. Given the higher-than-expected volume and price surcharge actions in Batesville, we are updating our full year outlook for fiscal '22. We now expect consolidated revenue in the range of $2.88 billion to $2.96 billion, a year-over-year increase of 3% to 6% compared to our previous guidance which anticipated growth of 1% to 4%. We are tightening our range for full year adjusted earnings per share to be $3.80 to $4 compared to our previous guidance of $3.70 to $4. 22:50 We expect our annual adjusted effective tax rate to now be 28% to 30% compared to our previous estimate of 27% to 29%. We expect Batesville revenue to be down 5% to 6% versus our previous expectation of down 11% to 13%. We are increasing our expectation for Batesville margin to be in the range of 20% to 21% compared to our previous guidance of 19% to 20%. Approximately half of the increase in our top line expectation for Batesville is attributed to the price surcharge, which is fully offset by inflation on a dollar-for-dollar basis. 23:35 We are maintaining our full year revenue and margin expectations for the APS and MTS segments but remain cautious given the continued uncertainty in the global supply chain. For our fiscal second quarter, we expect adjusted EPS in the range of $0.96 to $1.02. We expect COVID volume for Batesville to be lower than Q1, but overall revenue will be approximately flat due to the additional price surcharge. However, we expect margin will be down from Q1 due to the lower volume and the price surcharge being fully offset by inflation on a dollar-for-dollar basis. 24:19 We expect APS revenue to be in line with Q1 with moderately higher margin. And lastly, for MTS, we expect modest revenue growth compared to Q1 driven by a sequential increase in revenue for injection molding equipment, partially offset by a decline in hot runner sales due to normal seasonality from the Chinese New Year. 24:44 We expect MTS margin to be slightly lower compared to Q1 due to unfavorable product mix. Please review Slide 16 of the earnings presentation for additional guidance assumptions. 24:58 And now I'll turn the call back over to Kim.